Accepted: 6 October 2022
First Online: 17 November 2022
: S.I.S. has served in the following roles as an employee of UTHealth: site investigator in clinical trials sponsored by Athersys, KM Pharma, ReNeuron and SanBio, for which UTHealth has received payments on the basis of clinical trial contracts; investigator on clinical trials supported by the Cord Blood Registry Systems, the Department of Defense, Let’s Cure CP, NIH, and the TIRR Foundation; investigator in the Clinical and Translational Science Awards (CTSA) Program funded by the NIH; principal investigator or co-investigator on NIH-funded grants in basic science and clinical research; investigator for an imaging analysis centre for clinical trials sponsored by Athersys, ReNeuron and SanBio. He has also provided consulting services on behalf of UTHealth to Abbvie, ArunA, Deck Therapeutics, KM Pharma, Lumosa, Neurastasis, Neurexcell and ReNeuron. All compensation from such consulting arrangements has been paid to UTHealth. C.S.C. has royalty, equity and advisory board interests in Cellvation, which is developing cell therapies and an ex vivo mechanotransductive bioreactor for cell expansion. He also has sponsored research agreements with Athersys, Biostage and Generate Life Sciences, has served on the advisory board for Biostage and Generate Life Sciences, and is a consultant for Stream Biomedical.